Drug Topics
MAY 9, 2025
Stanley V. Campbell, Jr., CEO of EagleForce Associates, Inc., and Yi Deng, PhD, Senior Vice President of Engineering at EagleForce, discuss the basics of AI and how its assisting with compliance.
STAT
MAY 9, 2025
Less than two years ago, I completed a three-year emergency medicine residency and, after passing written and oral board exams, became a board-certified emergency physician. Now, the Accreditation Council for Graduate Medical Education is claiming that three years of personal and financial sacrifice are not enough. The ACGME reviews each specialty’s program requirements every 10 years, and it recently released their proposed updates for emergency medicine.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
MAY 9, 2025
Vin Gupta, MD, former Chief Medical Officer at Amazon Pharmacy and renowned US medical analyst, discusses pharmacists ability to reach communities and address social determinants of health.
Fierce Healthcare
MAY 9, 2025
Loss of services and support systems will result in the rollback of advancements made around human and civil rights for people with intellectual and developmental disabilities.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacy Times
MAY 9, 2025
The most substantial reduction was achieved 2 to 3 years after vaccination with a sustained protective effect lasting up to 8 years
The Guardian - Pharmaceutical Industry
MAY 9, 2025
Providing semaglutide for all those eligible may bring productivity gains as people are able to work more Giving weight loss jabs to everyone eligible for them could boost the UK economy by 4.5bn, according to research. Worldwide, about 3.8 billion people over 25 and just under 750 million children and young people are forecast to be overweight or obese by 2050.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
MAY 9, 2025
WASHINGTON — U.S. regulators have approved the first cervical cancer testing kit that allows women to collect their own sample at home before shipping it to a laboratory, according to a medical device company. Teal Health said Friday the Food and Drug Administration approved its Teal Wand for home use, offering a new way to collect vaginal samples that can detect the HPV virus that causes cervical cancer.
Pharmacy Times
MAY 9, 2025
Lacy La Fever, PharmD, MS, discussed outcomes associated with different carboplatin AUC dosing strategies.
Pharmaceutical Commerce
MAY 9, 2025
Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.
Pharmacy Times
MAY 9, 2025
These findings demonstrate an association that is independent of the diseases genetic predisposition.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmaceutical Technology
MAY 9, 2025
The US Food and Drug Administration (FDA) has set an "aggressive" timeline to implement genAI across the agency by 30 June 2025.
Pharmacy Times
MAY 9, 2025
Abemaciclib and ribociclib have various risks and benefits in treating early breast cancer, highlighting the importance of patient-provider communication.
Viseven
MAY 9, 2025
When faced with life-or-death treatment decisions, healthcare stakeholders need more than clinical data alone they need a complete picture of both effectiveness and value. Health Economics and Outcomes Research (HEOR) delivers this by uncovering the true impact of therapies on patient outcomes , healthcare costs, and quality of life. For the pharmaceutical industry, HEOR isnt just an analytical tool, its a strategic necessity, shaping decisions that determine market access, pricing, and long-te
Pharmacy Times
MAY 9, 2025
Plozasiran shows promise in reducing cholesterol and triglyceride levels in patients with mixed hyperlipidemia and other harmful conditions, addressing significant cardiovascular risks.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
The Thyroid Pharmacist
MAY 9, 2025
Over the years of working with people with Hashimotos, it has become clear to me that there is a strong relationship between sex hormones and thyroid hormones. One clients story comes to mind as one that will resonate with many of you. At the time, this client had just turned 40 and started to see some changes in her previously very regular cycle, including mid-cycle spotting and a heavier flow.
The Checkup by Singlecare
MAY 9, 2025
Qulipta ( atogepant ) is a brand-name prescription medication used to prevent migraine headaches (both chronic and episodic migraines ). Currently, Qulipta is not available as a generic medicine. Qulipta is a type of calcitonin gene-related peptide ( CGRP ) receptor antagonist. Migraines are associated with increased levels of a protein called CGRP in the brain, and Qulipta helps to block CGRP receptors from being activated.
Pharmacy Times
MAY 9, 2025
New research reveals a promising strategy to slow type 1 diabetes progression by targeting inflammation with an existing psoriasis drug.
Pharmafile
MAY 9, 2025
Clinical biotech, Galimedix Therapeutics, has announced the completion of a single ascending dose (SAD) part of a phase 1 study of GAL-101, a novel therapy aimed to treat serious neurodegenerative eye and brain conditions. The SAD study showed that GAL-101 was well-tolerated and has a strong safety and pharmacokinetic profile. These promising results have allowed […] The post Galimedix completes key stage of clinical trial for treatment targeting eye and brain diseases appeared first on Ph
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
PharmExec
MAY 9, 2025
The Avmapki Fakzynja Co-Pack marks the first FDA-approved treatment for adult patients with KRAS-mutated recurrent low-grade serous ovarian cancer who have received prior systemic therapy.
Pharmacy Times
MAY 9, 2025
A recent study highlights the promising immune response and safety of the Arexvy vaccine in lung transplant recipients, crucial for preventing RSV infections.
pharmaphorum
MAY 9, 2025
Cost-related nonadherence (CRN) the act of skipping doses, splitting pills, or delaying refills to save money is a major issue among US adults with chronic conditions.
Pharmaceutical Commerce
MAY 9, 2025
Ways to reimagine pharmas operating model and KPIs for commercial success in an AI-driven future.
Pharmaceutical Technology
MAY 9, 2025
Bavarian Nordic is successfully navigating a sentiment-changing vaccine landscape, posting Q1 revenues significantly up from Q1 2024.
PharmaVoice
MAY 9, 2025
The head of HHS is seeking the “root causes” of autism spectrum disorder through a large government research project.
Pharmaceutical Technology
MAY 9, 2025
Haya Therapeutics has secured $65m in Series A funding to expedite the clinical development of HTX-001 for treating heart failure.
The Thyroid Pharmacist
MAY 9, 2025
At the time I was first diagnosed with Hashimotos, I knew that I was not yet ready to start a family. With my health being less than optimal, it was obvious to me that an unplanned pregnancy would wreak havoc on my health, and that I would need to postpone any plans to have children. At the same time, I was a pharmacist and knew through both training and my first-hand experience, that taking artificial hormones in the form of birth control pills was contributing to my poor health.
Fierce Healthcare
MAY 9, 2025
Volumes and spending declined from February to March, though limited efficiency gains and largely flat revenues bring some concerns with expense headwinds on the horizon, Kaufman Hall warned in its latest monthly report.
Pharmacy Times
MAY 9, 2025
Student pharmacists can work toward a better future for patients, themselves, and the profession.
Pharmafile
MAY 9, 2025
Private equity firm Apiary Capital has invested in performance-io (PIO), a specialist life sciences performance marketing and SEO agency, to accelerate its international growth and service expansion. Founded in London in 2018, PIO was the first SEO agency to serve highly regulated pharma and biotech markets. The company helps clients leverage upcoming technologies, especially artificial […] The post Apiary invests in life sciences SEO pioneer PIO to support global expansion appeared first
Pharma Marketing Network
MAY 9, 2025
What does it take to bring a life-saving therapy to market and ensure patients can actually access it? Behind every successful drug launch lies a labyrinth of negotiations, pricing models, and payer strategies. Understanding the pharmaceutical market access process is crucialnot only for commercialization teams but for marketers and strategists looking to position their brands competitively.
Pharmacy Times
MAY 9, 2025
Specialty pharmacy experts and key opinion leaders gathered at Asembias AXS25 Summit and discussed critical insights in interviews with Pharmacy Times.
STAT
MAY 9, 2025
WASHINGTON — President Trump is widely expected to try to advance a “most-favored nation” policy next week in an effort to reduce U.S. drug prices — a move that is likely to significantly rattle the pharmaceutical industry, cheer his political base, and, possibly, leave open some very big questions. The idea behind the policy, generally speaking, is simple: It would tie payments for drugs in the United States to prices paid by other high-income countries, many of whic
PharmExec
MAY 9, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Expert insights. Personalized for you.
Let's personalize your content